source
- Invivyd appoints chairman Marc Elia as CEO ahead of COVID antibody readoutInvivyd, an infectious-disease biotech, announced that its chairman Marc Elia will also serve as chief executive officer. Elia, who joined the board in 2022 and helped shape the company's scientif…
- Novartis and Bristol Myers pause autoimmune CAR-T trials after serious safety eventsNovartis and Bristol Myers Squibb announced the suspension of several autoimmune CAR‑T studies after encountering serious safety problems. In Novartis' trials, three participants died from a severe…